A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®(MMX®)) for active, mild-to-moderate ulcerative colitis

BACKGROUND: Cortiment®(MMX®) (budesonide MMX®) is currently approved for the induction of remission in mild-to-moderate ulcerative colitis (UC) patients when 5-ASA treatment is not sufficient. Data in real-life settings are lacking. METHODS: This was a multicentre observational prospective cohort st...

Full description

Saved in:
Bibliographic Details
Published in:United European Gastroenterol J
Main Authors: Danese, Silvio, Hart, Ailsa, Dignass, Axel, Fiorino, Gionata, Louis, Edouard, Bonovas, Stefanos, D'Haens, Geert, Dotan, Iris, Rogler, Gerhard, Paridaens, Kristine, Peyrin-Biroulet, Laurent
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826527/
https://ncbi.nlm.nih.gov/pubmed/31700630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619864848
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items